Global Digital Diabetes Management Market Gearing Up for 20% Growth by 2026

Global digital diabetes management market is gaining momentum due to increasing diabetes cases, adoption of cloud-based solutions, awareness of digital diabetes management solutions, and the rise of digital tools and mobile apps.

(firmenpresse) - Diabetes is a chronic disease that must be constantly managed. Diabetes patients who need to make lifestyle or pharmaceutical changes in response to glucose monitoring data might benefit from digital diabetes management systems. Clinical programs, services, and integrated technology are included in the digital diabetes management system to address people's requirements across the continuum of care.

Demand is being driven by technological advancements in digital diabetes management market

Digital health technology, particularly digital and health applications ('apps'), is fast evolving to help people in managing their diabetic condition.
For instance,

In March 2022, Glooko Inc. acquired DIABNEXT to increase its diabetes offerings in France. DIABNEXT’s mobile app complements Glooko’s product portfolio and tracks diabetes data

In February 2022, Terumo Corporation entered into an agreement with Diabeloop. Under the agreement, both the companies will be integrating therapeutic artificial intelligence to automate the treatment of type 1 diabetes

Rising Awareness Regarding Diabetes Self-Management Solutions Fuels the Digital Diabetes Management Market

Diabetes self-management encompasses diabetes education, healthy eating, physical exercise, medication, device use, monitoring, and adjusting behavior and drug dosages based on patient-generated data. Several players and governments from various nations are doing awareness campaigns/training to raise awareness.
For instance,

* Diabetes Self-Management Training (DSMT) Certification
* Diabetes Self-Management Education and Support (DSMES) services
* World Diabetes Day (WDD) is the world's largest diabetes awareness campaign

Get a FREE Sample report on Digital Diabetes Management Market @ https://meditechinsights.com/digital-diabetes-management-market/

Role of mHealth in Digital Diabetes Management Market Increases Demand



Diabetes is the most often addressed chronic clinical ailment by mHealth, followed by depression and asthma. Mobile health (mHealth) solutions have improved diabetes care and prevention and are expected to play a growing role as smartphone ownership and medical device developments increase.

For example,

* In May 2021, F. Hoffmann-la Roche joined up with Ellerca Health to launch Accu-Chek + 360Care, integrating Roche’s Accu-Chek Guide blood glucose meter, customized home delivery of testing strips, and Ellerca’s self-management digital program, 360Care

Key Challenges of the Digital Diabetes Management Market

Reimbursement difficulties in developing countries, high device costs, increased worries about data security, and a preference for traditional diabetes treatment over digital diabetes management Sare some of the constraints that are projected to impede market expansion include

North America is poised to maintain its dominant position in the digital diabetes management market

North America now controls a sizable portion of the worldwide digital diabetes management industry. North America is likely to maintain a significant position in the coming years, owing to the region's rising diabetes incidence and increased use of technologically sophisticated devices.

Competitive Landscape Analysis of the Digital Diabetes Management Market

Some of the key players competing in the market include Medtronic Plc, Abbott, F.Hoffmann-LA Roche Ltd, Senseonics, and Insulet Corporation, among others.

Organic and inorganic growth strategies used by firms to get a foothold in the Digital Diabetes Management Market

Players in this market are employing organic and inorganic growth strategies such as collaborations, acquisitions, and new product launches to obtain market share.

For instance,

* In April 2022, Dexcom released Dexcom ONE Continuous Glucose Monitoring System. The Dexcom ONE system is an easy-to-use real-time CGM (rt-CGM) that more cheaper and accessible for people with diabetes in the UK

* In April 2022, Abbott announced a collaboration with CamDiab and Ypsomed. The three businesses want to collaborate to develop and market an integrated automated insulin delivery (AID) system.

Explore Comprehensive Market insights on Digital Diabetes Management Market, Vist Us On @ https://meditechinsights.com/Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
PresseKontakt / Agentur:
Bereitgestellt von Benutzer: Prathamesh
Datum: 05.10.2023 - 12:08 Uhr
Sprache: Deutsch
News-ID 2066283
Anzahl Zeichen: 4849

Kontakt-Informationen:
Ansprechpartner: Prathamesh Medi Tech
Stadt:

Brussels

Telefon: 0498868079

Kategorie:

Gesundheitswesen - Medizin

Meldungsart: Finanzinformation
Versandart: Veröffentlichung
Freigabedatum: 10.05.2023

Diese Pressemitteilung wurde bisher 553 mal aufgerufen.

Growing Focus on Augmented Reality Spurs 13% CAGR in Global Bionic Contact Lense ...

Bionic contact lenses are an innovative blend of traditional contact lenses and advanced tech, promising to reshape vision correction and AR experiences by overlaying digital information in real time. They offer benefits such as addressing nearsighte ...

The Bioburden Testing Market Continues Upward Trend with a Projected 12-15% CAGR ...

Bioburden testing, an essential quality control process in pharmaceutical and medical device production, evaluates microbial contamination levels on products, raw materials, and manufacturing settings, including bacteria, fungi, yeasts, and molds. Th ...

The Cardiac Resuscitation Devices Market is Poised to achieve a CAGR of 6-7% by ...

Cardiopulmonary resuscitation (CPR), another name for cardiac resuscitation, is an emergency treatment given to people who are experiencing cardiac arrest—a condition in which the heart stops beating efficiently—in an emergency. In order to susta ...

Alle Meldungen von Medi-tech insights